In an analysis of resistin expression and clinical status in breast cancer tissue samples, high BMI (>24 kg/m2) and resistin positivity was associated with a 5-fold higher likelihood of pathological grade III disease as compared with resistin negativity (OR: 5.020; 95% CI: 1.380-18.259) (Table 5). Here, RETN is linked to breast cancer.